In a review of repurposing medications for pulmonary arterial hypertension treatment, dichloroacetate, metformin, and rosiglitazone/pioglitazone had the most preclinical data to support their use.
Researchers examined the effects of acutely inhaled iloprost on right ventricular physiology.
Researchers sought to determine the safety of left main coronary artery stenting in patients with pulmonary arterial hypertension and extrinsic left main coronary artery compression.
A panel of experts and organizational representatives updated the 2014 CHEST guidelines for pulmonary arterial hypertension therapy.
Treatment success in systemic lupus erythematosus-associated pulmonary arterial hypertension, as defined by the European Society of Cardiology and the European Respiratory Society, is associated with long-term survival and supports a treat-to-target strategy.
End-systolic volume index is one of the most significant components of right ventricular stroke work penalized by ejection fraction in patients with worsening states of pulmonary arterial hypertension.
Alyq should not be used with concomitant organic nitrates or guanylate cyclase (GC) stimulators (eg, riociguat), and in patients with a known serious hypersensitivity to tadalafil.
Investigators sought to determine whether patients with rheumatic heart disease and preoperative pulmonary arterial hypertension who undergo cardiac surgery experience poor outcomes.
Patients with pulmonary arterial hypertension had lower pulmonary gradient of methemoglobin compared with control patients.
Heritable pulmonary arterial hypertension involves mutations in genes other than Bone Morphogenetic Protein Receptor Type 2 (BMPR-2).
